| Literature DB >> 28724695 |
Gyeongjun Cho1, Junheon Kim2, Chung Gyoo Park1, Corey Nislow3, David M Weller4, Youn-Sig Kwak5.
Abstract
Streptomyces spp. have the ability to produce a wide variety of secondary metabolites that interact with the environment. This study aimed to discover antifungal volatiles from the genus Streptomyces and to determine the mechanisms of inhibition. Volatiles identified from Streptomyces spp. included three major terpenes, geosmin, caryolan-1-ol and an unknown sesquiterpene. antiSMASH and KEGG predicted that the volatile terpene synthase gene clusters occur in the Streptomyces genome. Growth inhibition was observed when fungi were exposed to the volatiles. Biological activity of caryolan-1-ol has previously not been investigated. Fungal growth was inhibited in a dose-dependent manner by a mixture of the main volatiles, caryolan-1-ol and the unknown sesquiterpene, from Streptomyces sp. S4-7. Furthermore, synthesized caryolan-1-ol showed similar antifungal activity. Results of chemical-genomics profiling assays showed that caryolan-1-ol affected the endomembrane system by disrupting sphingolipid synthesis and normal vesicle trafficking in the fungi.Entities:
Keywords: Streptomyces; antifungal activity; caryolan-1-ol; endomembrane system; volatile
Mesh:
Substances:
Year: 2017 PMID: 28724695 PMCID: PMC5541347 DOI: 10.1098/rsob.170075
Source DB: PubMed Journal: Open Biol ISSN: 2046-2441 Impact factor: 6.411
Figure 1.Control of fungal infection of strawberries by S4–7 volatiles. This test was conducted at room temperature. (a) Botrytis cinerea colonization of strawberry; (b) Visualization of B. cinerea sign ratio. Error bars indicate standard deviations. Berries had less coverage of B. cinerea mycelia and spores in the presence of the S4–7 volatile than in the control (p = 0.026, t-test).
Secondary metabolism analysis of Streptomyces using antiSMASH.
| strain | antiSMASH | Blastp | |||||
|---|---|---|---|---|---|---|---|
| similar known terpene cluster | gene similarity (%) | size (bp) | terpene-related enzyme | total score | ident (%) | accession | |
| S4–7 | hopene biosynthesis | 69 | 26 574 | squalene-hopene cyclase | 1347 | 100 | WP044 373 054.1 |
| geranylgeranyl diphosphate synthase | 724 | 99 | SCF60437.1 | ||||
| squalene synthase HpnD | 630 | 99 | EWS95805.1 | ||||
| squalene synthase HpnC | 592 | 99 | WP 030800744.1 | ||||
| — | — | 21 056 | (+)-caryolan-1-ol synthase | 681 | 99 | SBU91888.1 | |
| isorenieratene biosynthesis | 85 | 26 117 | lycopene beta-cyclase | 813 | 100 | KIX34058.1 | |
| phytoene synthase | 694 | 100 | WP 030811369.1 | ||||
| geranylgeranyl pyrophosphate synthetase | 707 | 100 | KIX34053.1 | ||||
| — | — | 66 745 | 1509 | 100 | WP 044369842.1 | ||
| isorenieratene biosynthesis | 85 | 26 327 | geranylgeranyl pyrophosphate synthase | 753 | 99 | WP 044373694.1 | |
| phytoene synthase | 664 | 100 | WP 044373656.1 | ||||
| lycopene cyclase | 783 | 100 | WP 044373647.1 | ||||
| S8 | isorenieratene biosynthesis | 100 | 26 022 | geranylgeranyl diphosphate synthase | 822 | 100 | SCK22258.1 |
| phytoene synthase | 652 | 99 | SCK22276.1 | ||||
| lycopene beta-cyclase | 780 | 99 | SCK22321.1 | ||||
| hopene biosynthesis | 69 | 26 574 | squalene-hopene cyclase | 1342 | 99 | WP 028418748.1 | |
| geranylgeranyl diphosphate synthase, | 725 | 99 | SCD75724.1 | ||||
| squalene synthase HpnD | 624 | 99 | WP 028418746.1 | ||||
| squalene synthase HpnC | 594 | 99 | SCK56037.1 | ||||
| — | — | 21 056 | (+)- | 658 | 99 | SCK14242.1 | |
| — | — | 22 214 | 1503 | 99 | SCK19404.1 | ||
Figure 2.GC-MS (GC-2010 coupled with GCMS-QP2010 plus) analysis of S4–7 volatiles and synthetic caryolan-1-ol. (i) Geosmin; (ii and iv) caryolan-1-ol; (iii) unknown sesquiterpene. (a) GC of total ion current of synthetic caryolan-1-ol. S4–7 volatile and synthetic caryolan-1-ol have identical retention times (24 min). (b) Mass spectra comparison of S4–7 volatiles and synthetic caryolan-1-ol. Synthetic caryolan-1-ol (iv) mass spectrum coincides with S4–7 caryolan-1-ol (ii).
Figure 3.Growth inhibition of B. cinerea by synthetic caryolan-1-ol. (a) Growth ratio using box-and-whisker plots. (b) Growth of B. cinerea at 4 days. Acetone (10 μl) was used as a control treatment. Synthetic caryolan-1-ol inhibited the growth and spore formation.
Figure 4.Genes affected by caryolan-1-ol. Thirty-three deletion strains with a fitness defect score of 3.3 or greater were selected.
Figure 5.Network analysis of high defect score for the top 15 genes. Visualization was perfomed by GeneMANIA (http://genemania.org). Genes are functionally grouped into sphingolipid, cellular response to omotic stress and late endosome to vacuole transport.
Figure 6.Caryolan-1-ol affects very long chain fatty acid and ceramide-based lipid biosynthesis pathways. The illustration shows the sphingolipid synthesis pathway in yeast. Blue lines show synthetic pathway and red letters indicate genes with high fitness defect score (greater than 3.3) in figure 4.
GO term analysis of the high fitness defect score genes in HOP assay (p > 0.05). FDR, false discovery rate; EFP, expected false positives.
| Gene Ontology term | cluster frequency | background frequency | FDR | EFP | genes annotated to the term | ||
|---|---|---|---|---|---|---|---|
| component | endomembrane system | 14/33 genes (42.4%) | 978/7165 background genes (13.6%) | 0.004 | 0.00% | 0.00 | CSG2, RER1, VMS1, SNF1, VPS52, EUG1, DID4, SUR4, SCS7, KTR5, SIP3, LRO1, BRO1, VPS4 |
| process | intralumenal vesicle formation | 3/33 genes (9.1%) | 7/7165 background genes (0.1%) | 0.001 | 0.00% | 0.00 | DID4, BRO1, VPS4 |
| endosome organization | 3/33 genes (9.1%) | 16/7165 background genes (0.2%) | 0.012 | 0.02% | 0.04 | DID4, BRO1, VPS4 | |
| maintenance of location | 4/33 genes (12.1%) | 45/7165 background genes (0.6%) | 0.013 | 0.01% | 0.04 | RER1, DID4, LRO1, VPS4 | |
| sphingolipid metabolic process | 4/33 genes (12.1%) | 45/7165 background genes (0.6%) | 0.013 | 0.01% | 0.04 | CSG2, SUR4, SCS7, LRO1 | |
| biological regulation | 18/33 genes (54.5%) | 1597/7165 background genes (22.3%) | 0.014 | 0.01% | 0.04 | CSG2, SMP1, RER1, VMA9, HPR1, SNF1, VPS52, GIN4, MIG3, DID4, FKS1, STE11, MGS1, SIP3, LRO1, COT1, BRO1, VPS4 | |
| endosomal transport | 5/33 genes (15.2%) | 102/7165 background genes (1.4%) | 0.024 | 0.02% | 0.10 | VPS52, DID4, SUR4, BRO1, VPS4 | |
| regulation of biological quality | 9/33 genes (27.3%) | 429/7165 background genes (6.0%) | 0.025 | 0.01% | 0.10 | CSG2, RER1, VMA9, VPS52, DID4, FKS1, LRO1, COT1, VPS4 | |
| late endosome to vacuole transport | 4/33 genes (12.1%) | 55/7165 background genes (0.8%) | 0.028 | 0.01% | 0.10 | DID4, SUR4, BRO1, VPS4 | |
| membrane budding | 3/33 genes (9.1%) | 22/7165 background genes (0.3%) | 0.034 | 0.02% | 0.14 | DID4, BRO1, VPS4 | |